InvestorsHub Logo

User-65225

11/10/18 7:23 PM

#69044 RE: mckinley1 #69042

This company doesn’t have any money to loan. The CEO cant even raise enough money to pay his own personal debts. lol

AMFE Is one of the fastest growing penny stocks and has barely needed to dilute over the past 3+ years, while still being able to fuel 8 figure growth, before their biggest initiatives even start adding to the numbers.

What has EAPH accomplished after all these years of hype? Crickets

Juancy

11/10/18 7:34 PM

#69045 RE: mckinley1 #69042

It is more than evident that EAPH is nothing more than a dilution machine with no revenues, no business direction, no audits, no bank account, no anything to keep investors interested except for a quick pump and dump. Where are the great initiatives that never came to fruition? Where are the revenues from the Bayer deal? Why were they doing illegal dumping in Georgina? Why make a 180 shift to real estate now?

[insert crickets here]

likwit

11/10/18 10:25 PM

#69047 RE: mckinley1 #69042

Except according to the books, you can look at it two ways. They never lent anything. 1. OR as soon as it was deemed profitable it looks like it was taken off the books and sold to an insider or private investor at a massive discount which represented a loss on the company books and all the gains were not reported in the companys financial statements as it was all kept by the insider or private investor which I am sure could be linked back to mean the same thing. Same way director as of last filing was collecting money since there was no bank account and has no interest in giving it to the company. Amazing management team here I must say.

I will ask one question and leave it at that. Where is the 200M medicated market shares that were issued, never given to MM as the deal never closed despite numerous press releases saying it did? Who has been selling those shares that have never left the market since the deal was being worked on?

Wait, no way. There's another one equally as bad? Damn.

http://eastonpharmaceuticalsinc.com/easton-pharmaceuticals-announces-finalization-of-agreement-for-the-acquisition-of-major-vaporizer-and-e-liquids-manufacturer-ibliss-inc-annual-sales-projected-to-once-again-reach-15000000-with-hea/

FINALIZATION OF AN AGREEMENT TO BRING IN MILLIONS!
Just one of many repeated deals that went nowhere.
ONCE AGAIN REACH $15M WITH 40% PROFIT MARGINS.
ALMOST TWO YEARS AGO AND $0 REVENUE TO DATE.

HOW MANY MORE EXAMPLES YOU NEED?